{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T02:04:32Z","timestamp":1746151472940},"reference-count":39,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2023,5,1]]},"DOI":"10.3724\/abbs.2023049","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T03:34:11Z","timestamp":1679024051000},"update-policy":"http:\/\/dx.doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["The FBXO32\/ATR\/ATM axis acts as a molecular switch to control the sensitivity of osteosarcoma cells to irradiation through its regulation of EXO1 expression"],"prefix":"10.3724","author":[{"given":"Yao","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panpan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ce","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaolu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"CITATION1","doi-asserted-by":"crossref","unstructured":"Namlos HM, Kresse SH, Muller CR, Henriksen J, Holdhus R, Saeter G,                                                      et al.                          Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern.                                                      Sarcoma                          2012, 2012:639038..","DOI":"10.1155\/2012\/639038"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1200\/JCO.2000.18.24.4016","volume":"18","author":"Bacci G","year":"2000","unstructured":"Bacci G, Ferrari S, Bertoni F, Ruggieri P, Picci P, Longhi A, Casadei R. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli\/osteosarcoma-2 protocol: an updated report. J Clin Oncol, 2000, 18: 4016-4027.","journal-title":"J Clin Oncol"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13028-017-0341-9","volume":"59","author":"Simpson S","year":"2017","unstructured":"Simpson S, Dunning MD, de Brot S, Grau-Roma L, Mongan NP, Rutland CS. Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics. Acta Vet Scand, 2017, 59:","journal-title":"Acta Vet Scand"},{"key":"CITATION4","doi-asserted-by":"crossref","unstructured":"Lu Y, Song T, Xue X, Cao G, Huang P. Kinesin superfamily proteins: roles in osteosarcoma.                                                      Front Biosci                          2021, 26: 370-378..","DOI":"10.52586\/4950"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/cncr.21263","volume":"104","author":"Mialou V","year":"2005","unstructured":"Mialou V, Philip T, Kalifa C, Perol D, Gentet JC, Marec-Berard P, Pacquement H. Metastatic osteosarcoma at diagnosis. Cancer, 2005, 104: 1100-1109.","journal-title":"Cancer"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1089\/jayao.2016.0078","volume":"6","author":"Kelleher FC","year":"2017","unstructured":"Kelleher FC, O\u2032Sullivan H. Monocytes, macrophages, and osteoclasts in osteosarcoma. J Adolesc Young Adult Oncol, 2017, 6: 396-405.","journal-title":"J Adolesc Young Adult Oncol"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1586\/erp.10.91","volume":"11","author":"Ruggieri P","year":"2011","unstructured":"Ruggieri P, Mavrogenis AF, Mercuri M. Quality of life following limb-salvage surgery for bone sarcomas. Expert Rev Pharmacoeconomics Outcomes Res, 2011, 11: 59-73.","journal-title":"Expert Rev Pharmacoeconomics Outcomes Res"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"12779","DOI":"10.1038\/s41598-020-69619-2","volume":"10","author":"Nytko KJ","year":"2020","unstructured":"Nytko KJ, Thumser-Henner P, Russo G, Weyland MS, Rohrer Bley C. Role of HSP70 in response to (thermo)radiotherapy: analysis of gene expression in canine osteosarcoma cells by RNA-seq. Sci Rep, 2020, 10:","journal-title":"Sci Rep"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00280-014-2392-1","volume":"73","author":"Ahmed AA","year":"2014","unstructured":"Ahmed AA, Zia H, Wagner L. Therapy resistance mechanisms in Ewing\u2019s sarcoma family tumors. Cancer Chemother Pharmacol, 2014, 73: 657-663.","journal-title":"Cancer Chemother Pharmacol"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1200\/JCO.2002.20.3.776","volume":"20","author":"Bielack SS","year":"2002","unstructured":"Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol, 2002, 20: 776-790.","journal-title":"J Clin Oncol"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13569-019-0119-0","volume":"9","author":"de Jong Y","year":"2019","unstructured":"de Jong Y, Ingola M, Briaire-de Bruijn IH, Kruisselbrink AB, Venneker S, Palubeckaite I. Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genes. Clin Sarcoma Res, 2019, 9:","journal-title":"Clin Sarcoma Res"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.molcel.2004.11.032","volume":"17","author":"Cotta-Ramusino C","year":"2005","unstructured":"Cotta-Ramusino C, Fachinetti D, Lucca C, Doksani Y, Lopes M, Sogo J, Foiani M. Exo1 processes stalled replication forks and counteracts fork reversal in checkpoint-defective cells. Mol Cell, 2005, 17: 153-159.","journal-title":"Mol Cell"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/ijms20010074","volume":"20","author":"Keijzers G","year":"2019","unstructured":"Keijzers G, Bakula D, Petr M, Madsen N, Teklu A, Mkrtchyan G, Osborne B. Human exonuclease 1 (EXO1) regulatory functions in DNA replication with putative roles in cancer. Int J Mol Sci, 2019, 20:","journal-title":"Int J Mol Sci"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1080\/15384101.2018.1534511","volume":"17","author":"Dai Y","year":"2018","unstructured":"Dai Y, Tang Z, Yang Z, Zhang L, Deng Q, Zhang X, Yu Y. EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients. Cell Cycle, 2018, 17: 2386-2397.","journal-title":"Cell Cycle"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.pharmthera.2014.12.001","volume":"149","author":"Weber AM","year":"2015","unstructured":"Weber AM, Ryan AJ. ATM and ATR as therapeutic targets in cancer. Pharmacol Ther, 2015, 149: 124-138.","journal-title":"Pharmacol Ther"},{"key":"CITATION16","unstructured":"Fan J, Zhao Y, Yuan H, Yang J, Li T, He Z, et al. Phospholipase C-epsilon regulates bladder cancer cells via ATM\/EXO1.                                                      Am J Cancer Res                         . 2020, 10: 2319-2336.."},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"10779","DOI":"10.1074\/jbc.M116.772475","volume":"292","author":"Tomimatsu N","year":"2017","unstructured":"Tomimatsu N, Mukherjee B, Harris JL, Boffo FL, Hardebeck MC, Potts PR, Khanna KK. DNA-damage-induced degradation of EXO1 exonuclease limits DNA end resection to ensure accurate DNA repair. J Biol Chem, 2017, 292: 10779-10790.","journal-title":"J Biol Chem"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"16202","DOI":"10.1074\/jbc.M115.645978","volume":"290","author":"Mei Z","year":"2015","unstructured":"Mei Z, Zhang D, Hu B, Wang J, Shen X, Xiao W. FBXO32 targets c-myc for proteasomal degradation and inhibits c-myc activity. J Biol Chem, 2015, 290: 16202-16214.","journal-title":"J Biol Chem"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"8878","DOI":"10.3892\/ol.2018.8367","volume":"15","author":"Yang C","year":"2018","unstructured":"Yang C, Fan P, Zhu S, Yang H, Jin X, Wu H. 3F\u2011Box protein 32 degrades ataxia telangiectasia and Rad3\u2011related and regulates DNA damage response induced by gemcitabine in pancreatic cancer. Oncol Lett, 2018, 15:","journal-title":"Oncol Lett"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"101289","DOI":"10.1016\/j.tranon.2021.101289","volume":"16","author":"Lu Y","year":"2022","unstructured":"Lu Y, Cao G, Lan H, Liao H, Hu Y, Feng H, Liu X. Chondrocyte-derived exosomal miR-195 inhibits osteosarcoma cell proliferation and anti-apoptotic by targeting KIF4A in vitro and in vivo. Transl Oncol, 2022, 16:","journal-title":"Transl Oncol"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.7150\/thno.43150","volume":"10","author":"Huang P","year":"2020","unstructured":"Huang P, Liao R, Chen X, Wu X, Li X, Wang Y, Cao Q. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer. Theranostics, 2020, 10: 4644-4658.","journal-title":"Theranostics"},{"key":"CITATION22","unstructured":"Gatzka M, Prisco M, Baserga R. Stabilization of the Ras oncoprotein by the insulin-like growth factor 1 receptor during anchorage-independent growth.                                                      Cancer Res                          2000, 60: 4222\u20134230.."},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1038\/s41418-020-00710-x","volume":"28","author":"Habel N","year":"2021","unstructured":"Habel N, El-Hachem N, Soysouvanh F, Hadhiri-Bzioueche H, Giuliano S, Nguyen S, Hor\u00e1k P. FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. Cell Death Differ, 2021, 28: 1837-1848.","journal-title":"Cell Death Differ"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"Barrett T","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA. NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res, 2013, 41: D991-D995.","journal-title":"Nucleic Acids Res"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1001\/jama.2016.0082","volume":"315","author":"Jacob JA","year":"2016","unstructured":"Jacob JA. Researchers turn to canine clinical trials to advance cancer therapies. Jama, 2016, 315:","journal-title":"Jama"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/stem.1596","volume":"32","author":"Desai A","year":"2014","unstructured":"Desai A, Qing Y, Gerson SL. Exonuclease 1 is a critical mediator of survival during DNA double strand break repair in nonquiescent hematopoietic stem and progenitor cells. Stem Cells, 2014, 32: 582-593.","journal-title":"Stem Cells"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1128\/MCB.00945-08","volume":"29","author":"Dherin C","year":"2009","unstructured":"Dherin C, Gueneau E, Francin M, Nunez M, Miron S, Liberti SE, Rasmussen LJ. Characterization of a highly conserved binding site of mlh1 required for exonuclease I-dependent mismatch repair. Mol Cell Biol, 2009, 29: 907-918.","journal-title":"Mol Cell Biol"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"e918751","DOI":"10.12659\/MSM.918751","volume":"26","author":"He D","year":"2020","unstructured":"He D, Li T, Sheng M, Yang B. Exonuclease 1 (Exo1) participates in mammalian non-homologous end joining and contributes to drug resistance in ovarian cancer. Med Sci Monit, 2020, 26:","journal-title":"Med Sci Monit"},{"key":"CITATION29","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-GMB-2019-0066","volume":"43(1 Suppl 1): e20190066","author":"Sousa JF","year":"2020","unstructured":"Sousa JF, Serafim RB, Freitas LM, Fontana CR, Valente V. DNA repair genes in astrocytoma tumorigenesis, progression and therapy resistance. Genet Mol Biol, 2020, 43(1 Suppl 1): e20190066:","journal-title":"Genet Mol Biol"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/nar\/gkp1164","volume":"38","author":"Bolderson E","year":"2010","unstructured":"Bolderson E, Tomimatsu N, Richard DJ, Boucher D, Kumar R, Pandita TK, Burma S. Phosphorylation of Exo1 modulates homologous recombination repair of DNA double-strand breaks. Nucleic Acids Res, 2010, 38: 1821-1831.","journal-title":"Nucleic Acids Res"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"7506","DOI":"10.3390\/ijms23147506","volume":"23","author":"Soni A","year":"2022","unstructured":"Soni A, Duan X, Stuschke M, Iliakis G. ATR contributes more than ATM in intra-S-phase checkpoint activation after IR, and DNA-PKcs facilitates recovery: evidence for modular integration of ATM\/ATR\/DNA-PKcs functions. Int J Mol Sci, 2022, 23:","journal-title":"Int J Mol Sci"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"8255","DOI":"10.1038\/s41598-019-44771-6","volume":"9","author":"Mladenov E","year":"2019","unstructured":"Mladenov E, Fan X, Dueva R, Soni A, Iliakis G. Radiation-dose-dependent functional synergisms between ATM, ATR and DNA-PKcs in checkpoint control and resection in G2-phase. Sci Rep, 2019, 9:","journal-title":"Sci Rep"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1080\/15384101.2015.1060381","volume":"14","author":"Bologna S","year":"2015","unstructured":"Bologna S, Altmannova V, Valtorta E, Koenig C, Liberali P, Gentili C, Anrather D. Sumoylation regulates EXO1 stability and processing of DNA damage. Cell Cycle, 2015, 14: 2439-2450.","journal-title":"Cell Cycle"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.1172\/JCI70559","volume":"123","author":"Kansara M","year":"2013","unstructured":"Kansara M, Leong HS, Lin DM, Popkiss S, Pang P, Garsed DW, Walkley CR. Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation. J Clin Invest, 2013, 123: 5351-5360.","journal-title":"J Clin Invest"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"9109","DOI":"10.1093\/nar\/gkaa631","volume":"48","author":"Sun X","year":"2020","unstructured":"Sun X, Wang Y, Ji K, Liu Y, Kong Y, Nie S, Li N. NRF2 preserves genomic integrity by facilitating ATR activation and G2 cell cycle arrest. Nucleic Acids Res, 2020, 48: 9109-9123.","journal-title":"Nucleic Acids Res"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1158\/1078-0432.CCR-15-0479","volume":"21","author":"Karnitz LM","year":"2015","unstructured":"Karnitz LM, Zou L. Molecular pathways: targeting ATR in cancer therapy. Clin Cancer Res, 2015, 21: 4780-4785.","journal-title":"Clin Cancer Res"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/labinvest.2009.138","volume":"90","author":"Chou JL","year":"2010","unstructured":"Chou JL, Su HY, Chen LY, Liao YP, Hartman-Frey C, Lai YH, Yang HW. Promoter hypermethylation of FBXO32, a novel TGF-\u03b2\/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. Lab Invest, 2010, 90: 414-425.","journal-title":"Lab Invest"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/cncr.28764","volume":"120","author":"Guo W","year":"2014","unstructured":"Guo W, Zhang M, Shen S, Guo Y, Kuang G, Yang Z, Dong Z. Aberrant methylation and decreased expression of the TGF-\u03b2\/Smad target gene FBXO32 in esophageal squamous cell carcinoma. Cancer, 2014, 120: 2412-2423.","journal-title":"Cancer"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41467-020-14870-4","volume":"11","author":"Wang X","year":"2020","unstructured":"Wang X, Qin G, Liang X, Wang W, Wang Z, Liao D, Zhong L. Targeting the CK1\u03b1\/CBX4 axis for metastasis in osteosarcoma. Nat Commun, 2020, 11:","journal-title":"Nat Commun"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/F1EFBAE8C6C449C1888F095DDD99B245","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2023049","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/F1EFBAE8C6C449C1888F095DDD99B245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T01:32:45Z","timestamp":1685583165000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2023049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":39,"URL":"https:\/\/doi.org\/10.3724\/abbs.2023049","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,1]]}}}